SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

VENUS REMEDIES

BSE: 526953 29 Jun 2025
Healthcare
₹ 433
Venus Remedies Ltd. specializes in Pharmaceuticals within the Healthcare sector.

VENUS REMEDIES - Share Price & Details

Market Cap
₹579.0
High /Low
477.0 / 270.0
Stock P/E
14.8
Book Value
₹420.0
Dividend Yield
0.0
ROCE
11.4
ROE
₹7.45
Face Value
10.0
PEG Ratio
0.21
EVEBITDA
₹5.93
Debt
1.69
CMP / FCF
14.3
Debt to equity
₹0.0
NP Ann
45.3
High price all time
639.0
Piotroski score
₹7.0
Graham Number
566.0
No. Eq. Shares
1.34
Net CF
₹9.18
Net profit
45.3
Price to book value
1.03
Interest Coverage
₹886.0
Low price all time
18.8
Industry PE
32.0
Reserves
₹548
Free Cash Flow
₹68.6

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
VENUS REMEDIES LTD.NANANANA579.014.8
Shukra Pharmaceuticals LimitedNANANANA57960.5
JENBURKT PHARMACEUTICALS LTD.NANANANA57417.9

Peer Comparison Chart


About VENUS REMEDIES

Venus Remedies Ltd., with Security Code 526953, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Venus Remedies Ltd Faces Trading Challenges Amid Declining Stock Performance

(13 Jun 2025)
Venus Remedies Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, faced notable trading activity, hitting its lower circuit...
Read more →

Has Venus Remedies declared dividend?

(07 Jun 2025)
Yes, Venus Remedies Ltd has declared a 30% dividend, amounting to ₹3 per share, with an ex-date of September 23, 2013.
Read more →

Venus Remedies Achieves 52-Week High Amid Broader Market Challenges

(02 Jun 2025)
Venus Remedies has achieved a new 52-week high of Rs. 460.6, reflecting a strong upward trend in its stock performance. The company has outperformed its...
Read more →

Venus Remedies' (NSE:VENUSREM) Solid Profits Have Weak Fundamentals

(02 Jun 2025)
Unsurprisingly, Venus Remedies Limited's ( NSE:VENUSREM ) stock price was strong on the back of its healthy earnings...
Read more →

Venus Remedies Limited (NSE:VENUSREM) Stock Catapults 26% Though Its Price And Business Still Lag The Market

(28 May 2025)
The Venus Remedies Limited ( NSE:VENUSREM ) share price has done very well over the last month, posting an excellent...
Read more →

AURUM PROPTECH LTD LEADS GAINERS IN B GROUP

(28 May 2025)
Venus Remedies Ltd, Apollo Micro Systems Ltd, India Pesticides Ltd and IVP Ltd are among the other gainers in the BSE's 'B' group today,...
Read more →